caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1093119653

Kimberly SchuelkeCNP

Nurse PractitionerMaplewood, MNI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (4)

CCN 240050
Hospital
CCN 240057
Hospital
CCN 240210
Hospital
CCN 240213
Hospital
REFERRAL NETWORK

Where Kimberly Schuelke's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 3 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
HEALTHEAST ST JOSEPHS HOSPITAL2141
HEALTHEAST ST. JOHN'S HOSPITAL1843
HEALTHEAST WOODWINDS HOSPITAL1120
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
Daniel Sipple
Physical Medicine and Rehabilitation · Edina, MN
1947
HEALTHEAST ST JOSEPHS HOSPITAL1839
HEALTHEAST ST. JOHN'S HOSPITAL1441
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
172
Unique beneficiaries
—
Total services
237
Distinct HCPCS
5
Medicare payment
$22K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 3,917 Nurse Practitioner providers in MN — above median (cohort median 222).
PRESCRIBING · PART D · 2024
Total Rx claims
779
Beneficiaries
—
Total drug cost
$12K
Distinct drugs
17
Brand share
16.4%
Top prescribed drugs
Gabapentin320 claims
Oxycodone Hcl/Acetaminophen68 claims
Cyclobenzaprine Hcl51 claims
Celecoxib46 claims
Tizanidine Hcl46 claims
QUALITY · MIPS · 2024
Final MIPS score
92.7
Quality
89.7
Cost
81.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.74%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.